Vertex Pharmaceuticals

Phone: +1 647-790-1600

Fax: +1 647 790 1645

Web: https://www.vrtx.ca/

Type	Public company
Traded as	Nasdaq: VRTX Nasdaq-100 component S&P 500 component
Industry	Pharmaceuticals & Biotherapeutics
Founded	1989 (1989)
Headquarters	Boston, Massachusetts, U.S.
Key people	Reshma Kewalramani, M.D., president and CEO Stuart A. Arbuckle, executive vice president and chief commercial officer Michael J. Parini, executive vice president and chief legal, administrative and business development officer Jeffrey Leiden, M.D., PhD, executive chairman David Altshuler, M.D., PhD, executive vice president, global research and chief scientific officer Amit K. Sachdev, executive vice president and chief patient officer
Products	Pharmaceuticals
Revenue	US$3.04 billion (2018)
Number of employees	3,900
Website	www.vrtx.com

Vertex creates new possibilities in medicine to cure diseases and improve people's lives. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society.

For detailed contact information visit location pages below.